Insulet Corp (NAS:PODD)
$ 199.42 2.91 (1.48%) Market Cap: 13.97 Bil Enterprise Value: 14.41 Bil PE Ratio: 60.40 PB Ratio: 17.65 GF Score: 84/100

Insulet Corp at Cowen Healthcare Conference (Virtual) Transcript

Mar 02, 2021 / 02:10PM GMT
Release Date Price: $265.91 (-1.61%)
Chris Lin
Cowen and Company, LLC, Research Division - VP of Health Care - Life Science and Diagnostic Tools

All right. Good morning, everyone. I'm Chris Lin, one of Cowen's health care analysts. It is my pleasure to welcome Insulet to our conference. From the company, we have Shacey Petrovic, who is President and CEO. We also have Wayde McMillan, who is CFO. So thanks for being here.

Shacey Petrovic
Insulet Corporation - President, CEO & Director

Great to be here, Chris.

Chris Lin
Cowen and Company, LLC, Research Division - VP of Health Care - Life Science and Diagnostic Tools

Great. So just to provide a quick road map, over the next 30 minutes, my goal is to cover 3 key topics including: one, the insulin pump market dynamics; two, Omnipod 5; and three, margin expansion targets. So with that, why don't we just jump into it?

Questions & Answers

Chris Lin
Cowen and Company, LLC, Research Division - VP of Health Care - Life Science and Diagnostic Tools

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot